BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Prostate cancer

1. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]